1. Wang, Yumeng, Wang, Congwen, Qiu, Junjun, Li, Guiling, Hua, Keqin. . Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer. In Journal for immunotherapy of cancer, 10, . doi:10.1136/jitc-2021-003667. https://pubmed.ncbi.nlm.nih.gov/35288463/
2. Li, Jiang, Xia, Qidong, Di, Can, Liu, Xinwei, Zhao, Qiyi. 2022. Tumor Cell-Intrinsic CD96 Mediates Chemoresistance and Cancer Stemness by Regulating Mitochondrial Fatty Acid β-Oxidation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2202956. doi:10.1002/advs.202202956. https://pubmed.ncbi.nlm.nih.gov/36581470/
3. Georgiev, Hristo, Ravens, Inga, Papadogianni, Georgia, Bernhardt, Günter. 2018. Coming of Age: CD96 Emerges as Modulator of Immune Responses. In Frontiers in immunology, 9, 1072. doi:10.3389/fimmu.2018.01072. https://pubmed.ncbi.nlm.nih.gov/29868026/
4. Law, Calvin, Wacleche, Vanessa Sue, Cao, Ye, Choi, Jaehyuk, Rao, Deepak A. 2024. Interferon subverts an AHR-JUN axis to promote CXCL13+ T cells in lupus. In Nature, 631, 857-866. doi:10.1038/s41586-024-07627-2. https://pubmed.ncbi.nlm.nih.gov/38987586/
5. Qiu, Junjun, Qu, Xinyu, Wang, Yumeng, Wang, Li, Hua, Keqin. 2023. Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2204951. doi:10.1002/advs.202204951. https://pubmed.ncbi.nlm.nih.gov/36725337/
6. Zhou, Wangying, Cai, Xiaobin, Liu, Feng. 2022. CD96 as a Potential Diagnostic Biomarker and New Target for Skin Cutaneous Melanoma. In Contrast media & molecular imaging, 2022, 6409376. doi:10.1155/2022/6409376. https://pubmed.ncbi.nlm.nih.gov/36043142/
智鼠故事 
